Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Region    |    News By Date    |    Business Directory
All Press Releases for February 25, 2010 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Dysport: Should Botox Users Switch and Save Money? Cosmeticsurgeryguru Investigates
Similar to Botox, Dysport is a botulinum toxin Type A injection for eliminating fine lines and wrinkles. It costs 20% less than Botox, despite needing two extra treatments 
x-small text small text medium text large text


    MANCHESTER, ENGLAND, February 25, 2010 /24-7PressRelease/ -- Dysport has entered the anti-wrinkle treatment arena against Botox and is looking to take a sizable chunk of the original's market share, which currently sits at 2.5 million treatments in America each year. Users have found that it's not only more affordable, but it may also produce superior results.

Made of botulinum toxin Type A proteins, the same substance as Botox, Dysport is injected into the muscle that causes wrinkles and fine lines to form on the skin's surface. This paralyzes the muscle and prevents it from creating those telltale marks. Because it is one-third the strength of the original product, it requires three treatments instead of just one. It is believed to have a number of benefits, however.

Experts have found Dysport produces results up to 48 hours sooner than Botox, which is a huge benefit for patients eager to get ready for an important event. Some patients have even reported results in as little as 24 hours. Even patients who have developed immunity to Botox have experienced results with this new wrinkle treatment.

Doctors have found this product can last up to a full year after the final treatment is administered, this is up to four times longer than the average lifespan of Botox treatments. The new injection also costs an estimated 20% less than the original wrinkle treatment.

"We've had a number of patients use both products, and have received mixed reviews. Some preferred Botox, while others have switched to Dysport and sworn to stay with it. Both products are quite similar, and carry the same risks, so which one patient chooses boils down to the specific area being treated, the patient's specific tissue type, and personal preference," explained CosmeticSurgeryGuru.com's Mike Brains.

Like Botox, Dysport is not without risks. These include unintended paralysis of muscles and the surrounding area, a burning sensation near the injection sites, bruising, and swelling. This version also has an expanded reach, which makes it the preferred treatment for larger areas, but it also carries an increased risk, particularly in sensitive areas such as around the eyes. Antibody formation is also more likely, meaning the body sends antibodies to neutralise it and prevent it from working.

It may have been originally created as a treatment for neurological disorders, but Dysport has proven itself as an effective tool against hyperhidrosis (excessive sweating of the skin) and wrinkles. Before choosing to switch, however, patients should consult their doctor or cosmetic surgeon.

www.cosmeticsurgeryguru.com


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #

Press Release Keywords:
Read more Press Releases from Matt Barr:
Other Press Release Headlines:

Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Social Media:
Share or bookmark this story using Facebook, Twitter, Digg, and more.

Bookmark and Share
Press Release Contact Information:
Matt Barr
Mediaedge:cia

Marketing
Eastgate, 2 Castle Street
Manchester, Greater Manchester
UK m3 4lz
Voice: 01619309000
Fax: 01619309030
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.